Search results
Why Moderna (MRNA) Stock Price Was Up 9% on Monday
Zacks via Yahoo Finance· 1 month agoModerna (MRNA) surges amid initiation reports of a phase II/III study on Merck-partnered experimental cancer therapy to treat patients with cutaneous...
Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 year agoZacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing...
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 month agoModerna (MRNA) witnessed a jump in share price last session on above-average trading volume. The...
Moderna (MRNA) Gains As Market Dips: What You Should Know
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) closed the most recent trading day at $145.36, moving +0.76% from the previous...
Moderna (MRNA) Beats on Q4 Earnings & Sales, Reiterates View
Zacks via Yahoo Finance· 2 months agoModerna, Inc. MRNA reported earnings of 55 cents per share in the fourth quarter of 2023, beating...
Why Moderna Stock Is Popping Over 20% Today
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) stock is skyrocketing higher today after cancer treatment news. In the video below, I break down the details and discuss whether...
An Intrinsic Calculation For Moderna, Inc. (NASDAQ:MRNA) Suggests It's 46% Undervalued
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights The projected fair value for Moderna is US$241 based on 2 Stage Free Cash Flow to...
Moderna (MRNA) Stock Moves -1.39%: What You Should Know
Zacks via Yahoo Finance· 3 months agoThe latest trading session saw Moderna (MRNA) ending at $101.05, denoting a -1.39% adjustment from...
Moderna (MRNA) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoInvestors focus will likely be on Moderna's (MRNA) pipeline, especially with its late-stage pipeline...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...
